Enjoy complimentary customisation on priority with our Enterprise License!
The antibiotics market size is forecast to increase by USD 16.63 billion at a CAGR of 5.67% between 2023 and 2028. The market is experiencing significant growth due to the rising prevalence of chronic diseases and hospital-acquired infections caused by various bacterial strains. However, the emergence of antibiotic-resistant strains poses a major challenge to market growth. To combat this trend, pharmaceutical companies are investing in research and development to create new antibiotics and improve existing ones for upper respiratory tract infection treatment. Strategic alliances and mergers and acquisitions (M&A) are also playing a crucial role in market consolidation and innovation. The market is expected to grow at a steady pace, driven by the increasing burden of infectious diseases and the need for effective antibiotic treatments.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.